市场调查报告书
商品编码
1306526
动脉粥状硬化斑块切除术和血管内碎石(IVL)设备的全球市场:规模,占有率,趋势,COVID-19影响分析(2023年~2029年):MedCoreAtherectomy & Intravascular Lithotripsy (IVL) Devices Market Size, Share, Trends & COVID19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Laser Atherectomy, Mechanical Atherectomy and IVL Devices. |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2022年,全球旋切术和血管内碎石机市场将达到8.01亿美元。预计在预测期内復合年增长率为 6.1%,到 2029 年将超过 12 亿美元。
本报告提供全球动脉粥状硬化斑块切除术与血管内碎石(IVL)设备市场相关调查,提供市场概要,以及各市场区隔,各地区趋势,竞争情形等资讯。
In 2022, the global market for atherectomy and Intravascular Lithotripsy devices reached a valuation of more than $801 million. It is projected to grow at a compound annual growth rate (CAGR) of 6.1% during the forecast period, surpassing $1.2 billion.
The market includes laser atherectomy, mechanical atherectomy, and IVL devices, and it is analyzed as a single entity without further segmentation.
In our comprehensive study on the global atherectomy devices market, iData Research has conducted an in-depth analysis of atherectomy and Intravascular lithotripsy procedure volumes. This analysis aims to enhance the accuracy of our market sizing and provide you with valuable insights into the volume of procedures conducted over a 10-year period across 70 countries.
Coronary atherectomy procedures are typically conducted after the identification of artery calcification through an angioplasty or other diagnostic procedure. While coronary physicians may not consider atherectomy as their primary choice, the number of atherectomy procedures is anticipated to rise in conjunction with the increasing utilization of angioplasty procedures.
The market for coronary atherectomy is expected to be limited by the efficacy of drug-eluting stents (DESs). The use of DESs provides cardiologists with a sense of confidence in preventing restenosis, potentially leading them to be less cautious in preparing the lesion before stent deployment. As the utilization of DESs becomes more prevalent in coronary procedures, the demand for atherectomy devices is likely to decline.
The global market for atherectomy and intravascular lithotripsy devices in 2022 was dominated by three key competitors: ShockWave Medical, Boston Scientific, and Cardiovascular Systems, Inc.
ShockWave Medical, as the leading competitor, specializes in IVL technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. Their device, ShockWave C2, has established a strong market presence.
Boston Scientific, the second-leading competitor, focuses on the mechanical atherectomy device market. While they continue to maintain competitiveness in this segment, they have experienced a decline in market share in recent years.
Cardiovascular Systems, Inc. (CSI) held the third-leading position in the coronary atherectomy device market. Their presence in the overall market was primarily attributed to their involvement in the mechanical atherectomy device segment, where they held a significant share.
Overall, these three competitors played a crucial role in shaping the atherectomy and IVL device market landscape in 2022.
Throughout our comprehensive research series, iData Research has extensively covered and analyzed over 70 countries worldwide. Each global region can be purchased as an individual report, allowing you to tailor the data specifically to your needs.